Analysis of treatment methods for liver cancer
DOI:
https://doi.org/10.54097/922vgn71Keywords:
liver cancer, treatment, application.Abstract
Cancer is a challenging disease to treat and has resulted in numerous fatalities. Among these cancers, liver cancer accounts for an important proportion of deaths from cancer and has become one of the main causes of human death. To this end, the treatment of liver cancer is of utmost importance, and scholars worldwide are exploring ways to cure it. Currently, several liver cancer treatment methods have significantly advanced. Different regions have varying treatment methods for liver cancer patients, including targeted drug therapy like sorafenib and the use of viruses to destroy cancer tissue. It is crucial to summarize the advantages and disadvantages of different treatment plans as they are suitable for different patients. This research will analyze existing therapies used in the treatment of liver cancer, highlighting their present situation with deficiencies. The relevant achievements of scholars from different countries are discussed to function as a reference for the subsequent development of liver cancer treatment.
Downloads
References
Torre L A, Siegel R L, Ward E M, et al. Global cancer incidence and mortality rates and trends—an update. Cancer epidemiology, biomarkers & prevention, 2016, 25 (1): 16 - 27.
Liu L, Cao Y, Chen C, et al. Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer research, 2006, 66 (24): 11851 - 11858.
Lencioni R, Kudo M, Ye S L, et al. GIDEON (Global Investigation of therapeutic DE cisions in hepatocellular carcinoma and of its treatment with sorafeNib): Second interim analysis. International journal of clinical practice, 2014, 68 (5): 609 - 617.
Lai C L, Lok A S F, Wu P C, et al. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial. Cancer, 1988, 62 (3): 479 - 483.
Russell S J, Peng K W, Bell J C. Oncolytic virotherapy. Nature biotechnology, 2012, 30 (7): 658 - 670.
Fukuhara H, Ino Y, Todo T. Oncolytic virus therapy: A new era of cancer treatment at dawn. Cancer science, 2016, 107 (10): 1373 - 1379.
Hodi F S, O'day S J, McDermott D F, et al. Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 2010, 363 (8): 711 - 723.
Geschwind J F H, Ko Y H, Torbenson M S, et al. Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production. Cancer research, 2002, 62 (14): 3909 - 3913.
Li S, Saw P E, Lin C, et al. Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. Biomaterials, 2020, 234: 119760.
Kabiri S, Rezaei F. Liver cancer treatment with integration of laser emission and microwave irradiation with the aid of gold nanoparticles. Scientific Reports, 2022, 1 2(1): 9271.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
